This HTML5 document contains 130 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33795926
rdf:type
wikibase:Item
schema:description
مقالهٔ علمی 2017 nî lūn-bûn artículu científicu espublizáu en 2017 научни чланак vedecký článok 2017년 논문 سائنسی مضمون wetenschappelijk artikel 2017年論文 мақолаи илмӣ artikull shkencor bilimsel makale 2017年论文 научная статья наукова стаття, опублікована в травні 2017 tieteellinen artikkeli مقالة علمية 2017年论文 artykuł naukowy articol științific 2017 թվականի մայիսին հրատարակված գիտական հոդված บทความทางวิทยาศาสตร์ 2017年論文 2017年の論文 scientific article teaduslik artikkel vetenskaplig artikel vědecký článek artikulong pang-agham научни чланак 2017年论文 tudományos cikk artículo científico publicado en 2017 мақолаи илмӣ 2017年論文 videnskabelig artikel (udgivet 2017) wissenschaftlicher Artikel ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article científic 2017年论文 vitskapeleg artikkel bài báo khoa học מאמר מדעי 2017年论文 2017年論文 naučni članak artigo científico (publicado na 2017) scienca artikolo επιστημονικό άρθρο artigo científico (publicado na 2017) научна статия 2017 թուականի Մայիսին հրատարակուած գիտական յօդուած articolo scientifico mokslinis straipsnis სამეცნიერო სტატია article scientific 2017年论文 artigo científico 2017年論文 vitenskapelig artikkel article scientifique (publié 2017)
p:P577
wds:Q33795926-F412835E-F0A3-45EA-ABCC-A5DE13A13454
wdt:P577
2017-05-01T00:00:00Z
p:P2860
wds:Q33795926-62F5850C-B41D-45B6-8203-012FA40B4DE5 wds:Q33795926-7E11E631-1C70-41F3-A9B4-2301813DE3D8 wds:Q33795926-180E6FF8-123D-41A5-8F67-A6CD5E14CF92 wds:Q33795926-000FB265-5431-459A-99AE-2FB93AF3C4DF wds:Q33795926-1EABCAA9-9C5A-45BB-A1C3-AB1E95D6B42E wds:Q33795926-C7E2A472-DE47-4DF4-8838-81C9A2F58E63 wds:Q33795926-CC53860B-F9AC-4CFA-9603-88B33718EB42 wds:Q33795926-9CADBB86-1F8A-42EE-B112-40DFBF87CB69 wds:Q33795926-C7DB047F-1C26-4F74-9239-BF4DE62F82F0 wds:Q33795926-C4F93849-45A2-4786-82B8-02C60C362873 wds:Q33795926-83B5F952-2F11-467D-BAEB-828D98E0EC61 wds:Q33795926-970DD8E3-368C-4451-A409-3981D3FF8282 wds:Q33795926-8825F769-F008-4B3F-A2E6-89F706247557 wds:Q33795926-FF33DF03-51BA-4C3F-81AD-FDFB2D6AD20C
wdt:P2860
wd:Q42827480 wd:Q36348589 wd:Q37826320 wd:Q61962687 wd:Q43282113 wd:Q53585481 wd:Q24658459 wd:Q47616993 wd:Q52845442 wd:Q33714912 wd:Q37299647 wd:Q37512383 wd:Q45054362 wd:Q83336818
p:P2093
wds:Q33795926-DAFFAF1F-8121-46CB-82EA-07B2B16A1D21 wds:Q33795926-CA5BD2DE-0E62-4C4E-A7C7-C5DE01ED31B0 wds:Q33795926-F2604A0D-17D4-4732-AD0F-F5569FA0C170 wds:Q33795926-878C43FD-126B-43E0-8D4A-376B98BAE6A9 wds:Q33795926-25E7DA1B-C15A-4300-9938-CCB35B608874 wds:Q33795926-2001101B-1A95-414F-991B-CEAA51B01309
wdt:P2093
Rajesh Kamalakar Todd Williamson Augustina Ogbonnaya Charlie Kreilick Erin A Zagadailov Michael Eaddy
rdfs:label
Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea
skos:prefLabel
Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea
schema:name
Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea
p:P1476
wds:Q33795926-30FF427A-4EBE-46DE-8BF3-37CB4A18CFC2
wdt:P1476
Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea
p:P304
wds:Q33795926-778F5ED1-DDC3-4227-BEA4-D7CF6888646F
wdt:P304
113-119
p:P31
wds:Q33795926-546E786B-0A31-4041-AEAB-0950EC4DA48C
wdt:P31
wd:Q13442814
p:P698
wds:Q33795926-9E7B2692-A40A-4062-B408-6E909223D430
wdtn:P698
n10:28626508
wdt:P698
28626508
p:P1433
wds:Q33795926-1C775E30-41B2-4408-90B2-4873B4980C8C
wdt:P1433
wd:Q26842282
p:P433
wds:Q33795926-E5CDB22A-03CE-4061-95F9-4DB74C69C031
p:P478
wds:Q33795926-E8C70A78-4168-468A-8086-E3A72ADA1E07
wdt:P433
3
wdt:P478
10
p:P932
wds:Q33795926-7D700DF6-0DBA-4CFC-914C-965FEF1D5A19
wdt:P932
5470237